Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 1/20 | 0.49 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.49 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.49 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.49 |
| ▸ | CALCR | P30988 | 4/20 | 0.48 |
| ▸ | F2 | P00734 | 4/20 | 0.48 |
| ▸ | NPY2R | P49146 | 7/20 | 0.48 |
| ▸ | NPY4R | P50391 | 7/20 | 0.48 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.48 |
| ▸ | NPY1R | P25929 | 5/20 | 0.48 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.48 |
| ▸ | CCKBR | P32239 | 2/20 | 0.47 |
| ▸ | GLP1R | P43220 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29531163 | 0.98 | CRHR1 (0.50) | HCRTR1HCRTR2CRHR1CRHR2CALCR | |
| SCHEMBL29530579 | 0.98 | CRHR1 (0.50) | HCRTR1HCRTR2CRHR1CRHR2CALCR | |
| SCHEMBL29530837 | 0.98 | CRHR1 (0.50) | HCRTR1HCRTR2CRHR1CRHR2CALCR | |
| SCHEMBL29530849 | 0.98 | CRHR1 (0.50) | HCRTR1HCRTR2CRHR1CRHR2CALCR | |
| SCHEMBL29530554 | 0.98 | HCRTR1 (0.49) | HCRTR1HCRTR2CRHR1CRHR2CALCR | |
| SCHEMBL32689779 | 0.93 | F2 (0.51) | HCRTR1HCRTR2CRHR1CRHR2CALCR | |
| SCHEMBL29530620 | 0.92 | CRHR1 (0.49) | HCRTR1HCRTR2CRHR1CRHR2CALCR | |
| SCHEMBL29530459 | 0.87 | CRHR1 (0.48) | HCRTR1HCRTR2CRHR1CRHR2CALCR | |
| SCHEMBL29530736 | 0.86 | C5AR1 (0.50) | HCRTR1HCRTR2CRHR1CRHR2CALCR | |
| SCHEMBL30974049 | 0.85 | CALCR (0.50) | HCRTR1HCRTR2CRHR1CRHR2CALCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4039710-B1 | ANTI-CD3 ANTIBODIES, ANTI-CD123 ANTIBODIES AND BISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO CD3 AND/OR CD123 | SANOFI SA (FR) | 2026-03-25 | — | — | EP | disclosed |
| EP-4039710-A2 | ANTI-CD3 ANTIBODIES, ANTI-CD123 ANTIBODIES AND BISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO CD3 AND/OR CD123 | SANOFI (FR) | 2022-08-10 | — | — | EP | disclosed |
| CN-114230668-A | anti-CD 3 antibodies, anti-CD 123 antibodies, and bispecific antibodies that specifically bind to CD3 and/or CD123 | 赛诺菲 | 2022-03-25 | — | — | CN | disclosed |
| CN-114230667-A | anti-CD 3 antibodies, anti-CD 123 antibodies, and bispecific antibodies that specifically bind to CD3 and/or CD123 | 赛诺菲 | 2022-03-25 | — | — | CN | disclosed |